Gastrointestinal Cancer MRTX849 Shows Promise for KRAS G12C Colorectal Cancer Treatment: KRYSTAL-1 Trial Mar 13, 2023
Gastrointestinal Cancer Futibatinib Shows Promise for Treating FGFR2-Rearranged Intrahepatic Cholangiocarcinoma: Phase 2 Study Mar 13, 2023
Colorectal Cancer,Gastrointestinal Cancer Breakwater Safety Lead-In Improves Outcomes in BRAFV600E mCRC Mar 13, 2023
Colorectal Cancer,Gastrointestinal Cancer Global Study Shows Fruquintinib Improves HRQoL in FRESCO-2 Trial Mar 13, 2023
Colorectal Cancer,Gastrointestinal Cancer EPOCH Trial: Optimizing Treatment Planning for Patient Subgroups Mar 13, 2023
Gastrointestinal Cancer,Liver Cancer Impact of ADAs on uHCC Treatment in HIMALAYA Phase 3 Study Mar 10, 2023
Gastrointestinal Cancer,Liver Cancer HRQoL Impact of Tislelizumab vs. Sorafenib in First-line uHCC: RATIONALE-301 Mar 10, 2023
Gastrointestinal Cancer,Liver Cancer LEAP-002 Study: Lenvatinib+Pembrolizumab vs Lenvatinib+Placebo in aHCC HRQoL Comparison Mar 10, 2023